MLchartDataset catalogue

dipyridamole

Term · Oncology and biomedicine · MLC-T-ONC-002485

  1. A drug that prevents blood cell clumping and enhances the effectiveness of fluorouracil and other chemotherapeutic agents.

  2. A synthetic agent derivative of pyrimido-pyrimidine, with antiplatelet properties. Dipyridamole inhibits adenosine uptake by platelets and endothelial cells, triggering an accumulation of cyclic adenosine monophosphate (cAMP), and inhibiting the stimulation of platelet aggregation by agents such as platelet activating factor and collagen.

Table 1. Record
IdentifierMLC-T-ONC-002485
FieldOncology and biomedicine
AbbreviationDP
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-002485",
  "term": "dipyridamole",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A drug that prevents blood cell clumping and enhances the effectiveness of fluorouracil and other chemotherapeutic agents.",
    "A synthetic agent derivative of pyrimido-pyrimidine, with antiplatelet properties. Dipyridamole inhibits adenosine uptake by platelets and endothelial cells, triggering an accumulation of cyclic adenosine monophosphate (cAMP), and inhibiting the stimulation of platelet aggregation by agents such as platelet activating factor and collagen."
  ],
  "abbreviation": "DP",
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dipyridamole/"
}

Record 6,052 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.